FDA
approval
· 2019-01-31
FDA Approved: ANTI-DIARRHEAL — Supplemental Application (CHAIN DRUG MARKETING ASSOCIATION INC.)
Summary
The FDA approved a supplemental application for ANTI-DIARRHEAL containing loperamide hydrochloride, submitted by Chain Drug Marketing Association Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ANTI-DIARRHEAL (LOPERAMIDE HYDROCHLORIDE)